Element Capital Management LLC Mirati Therapeutics, Inc. Transaction History

Element Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$43.65 - $78.95 $223,095 - $403,513	-5,111 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $163,552 - $242,414	5,111 New	5,111 $217,000
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $851,314 - $1.71 Million	-32,680 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $562,096 - $1.14 Million	32,680 New	32,680 $1 Million
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $220,388 - $331,018	-17,422 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$4.7 - $11.7 $422,060 - $1.05 Million	-89,800 Reduced 83.75%	17,422 $204,000
Q2 2017 Aug 14, 2017	BUY	N/A	107,222	107,222 $391,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.